Bruker's and M2Aind’s 2nd Mass Spectrometry Innovations in Pharma Meeting Wann: 18./19. March 2019 Wo: Mannheim University of Applied Sciences, Auditorium (Building C), Paul-Wittsack-Str. 10, 68163 Mannheim
Building on years of excellence in Mass Spectrometry, Bruker has developed a new set of technologies that are impacting the pharmacological related industry far beyond the traditional role of quantitation and process monitoring. From lead generation all the way through to pre-clinical assessment, drug companies are employing advanced MS- and SPR-based technologies in a wide range of drug discovery roles. Furthermore, Mass Spec imaging is now being utilized extensively in industry in DMPK applications and beyond.
Come join industry leaders from top pharma (Boehringer Ingelheim, GSK, Bayer, Servier, Merck KGaA, Bruker, Roche, Evosep) around the globe (Prof. Nathalie Agar, Harvard, Prof. Matthias Trost, Newcastle, Prof. Susumu Uchiyama, Osaka), as they present their perspectives on using these advances to streamline the drug development process.
Finden Sie weitere Informationen hier.